An update on barriers to adolescent human papillomavirus vaccination in the USA

Research output: Contribution to journalArticle

12 Scopus citations


Human papillomavirus is the most common sexually transmitted infection in the USA. It is the primary cause of almost all cervical cancers as well as several other cancers that affect both men and women. Adolescents of both genders can now prevent transmission of the most common oncogenic strains of human papillomavirus by obtaining a safe, three-dose vaccine series. However, despite its potential to save lives and reduce severe morbidity, many US adolescents have not been vaccinated. This is in contrast to other countries where high rates of vaccination are already reducing rates of cervical intra-epithelial neoplasia and genital warts. This article describes barriers recently reported among families in the USA and concludes with suggestions for improving uptake.

Original languageEnglish (US)
Pages (from-to)1377-1384
Number of pages8
JournalExpert Review of Vaccines
Issue number10
StatePublished - Oct 3 2015



  • awareness
  • barriers
  • cancer prevention
  • HPV vaccine
  • human papillomavirus
  • provider

ASJC Scopus subject areas

  • Immunology
  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this